Cargando…

Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania

BACKGROUND: Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it is not part of diagnostic routines in HIV pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzeck, Fabian C., Ngwale, Ramadhani, Msongole, Bernadeta, Hamisi, Marian, Abdul, Omary, Henning, Lars, Letang, Emilio, Mwaigomole, Geoffrey, Battegay, Manuel, Hatz, Christoph, Tanner, Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585939/
https://www.ncbi.nlm.nih.gov/pubmed/23469281
http://dx.doi.org/10.1371/journal.pone.0058468
_version_ 1782261240555372544
author Franzeck, Fabian C.
Ngwale, Ramadhani
Msongole, Bernadeta
Hamisi, Marian
Abdul, Omary
Henning, Lars
Letang, Emilio
Mwaigomole, Geoffrey
Battegay, Manuel
Hatz, Christoph
Tanner, Marcel
author_facet Franzeck, Fabian C.
Ngwale, Ramadhani
Msongole, Bernadeta
Hamisi, Marian
Abdul, Omary
Henning, Lars
Letang, Emilio
Mwaigomole, Geoffrey
Battegay, Manuel
Hatz, Christoph
Tanner, Marcel
author_sort Franzeck, Fabian C.
collection PubMed
description BACKGROUND: Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it is not part of diagnostic routines in HIV programs in many resource-limited countries although patients could benefit from optimized antiretroviral therapy covering both infections. Screening could be facilitated by rapid diagnostic tests for HBsAg. Operating experience with these point of care devices in HIV-positive patients in Sub-Saharan Africa is largely lacking. We determined the prevalence of HBV and Hepatitis C virus (HCV) infection as well as the diagnostic accuracy of the rapid test device Determine HBsAg in an HIV cohort in rural Tanzania. METHODS: Prospectively collected blood samples from adult, HIV-1 positive and antiretroviral treatment-naïve patients in the Kilombero and Ulanga antiretroviral cohort (KIULARCO) in rural Tanzania were analyzed at the point of care with Determine HBsAg, a reference HBsAg EIA and an anti-HCV EIA. RESULTS: Samples of 272 patients were included. Median age was 38 years (interquartile range [IQR] 32–47), 169/272 (63%) subjects were females and median CD4+ count was 250 cells/µL (IQR 97–439). HBsAg was detected in 25/272 (9.2%, 95% confidence interval [CI] 6.2–13.0%) subjects. Of these, 7/25 (28%) were positive for HBeAg. Sensitivity of Determine HBsAg was rated at 96% (95% CI 82.8–99.6%) and specificity at 100% (95% CI, 98.9–100%). Antibodies to HCV (anti-HCV) were found in 10/272 (3.7%, 95% CI 2.0–6.4%) of patients. CONCLUSION: This study reports a high prevalence of HBV in HIV-positive patients in a rural Tanzanian setting. The rapid diagnostic test Determine HBsAg is an accurate assay for screening for HBsAg in HIV-1 infected patients at the point of care and may further help to guide cART in Sub-Saharan Africa.
format Online
Article
Text
id pubmed-3585939
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35859392013-03-06 Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania Franzeck, Fabian C. Ngwale, Ramadhani Msongole, Bernadeta Hamisi, Marian Abdul, Omary Henning, Lars Letang, Emilio Mwaigomole, Geoffrey Battegay, Manuel Hatz, Christoph Tanner, Marcel PLoS One Research Article BACKGROUND: Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in Sub-Saharan Africa. Screening for HBV surface antigen (HBsAg) before initiation of combination antiretroviral therapy (cART) is recommended. However, it is not part of diagnostic routines in HIV programs in many resource-limited countries although patients could benefit from optimized antiretroviral therapy covering both infections. Screening could be facilitated by rapid diagnostic tests for HBsAg. Operating experience with these point of care devices in HIV-positive patients in Sub-Saharan Africa is largely lacking. We determined the prevalence of HBV and Hepatitis C virus (HCV) infection as well as the diagnostic accuracy of the rapid test device Determine HBsAg in an HIV cohort in rural Tanzania. METHODS: Prospectively collected blood samples from adult, HIV-1 positive and antiretroviral treatment-naïve patients in the Kilombero and Ulanga antiretroviral cohort (KIULARCO) in rural Tanzania were analyzed at the point of care with Determine HBsAg, a reference HBsAg EIA and an anti-HCV EIA. RESULTS: Samples of 272 patients were included. Median age was 38 years (interquartile range [IQR] 32–47), 169/272 (63%) subjects were females and median CD4+ count was 250 cells/µL (IQR 97–439). HBsAg was detected in 25/272 (9.2%, 95% confidence interval [CI] 6.2–13.0%) subjects. Of these, 7/25 (28%) were positive for HBeAg. Sensitivity of Determine HBsAg was rated at 96% (95% CI 82.8–99.6%) and specificity at 100% (95% CI, 98.9–100%). Antibodies to HCV (anti-HCV) were found in 10/272 (3.7%, 95% CI 2.0–6.4%) of patients. CONCLUSION: This study reports a high prevalence of HBV in HIV-positive patients in a rural Tanzanian setting. The rapid diagnostic test Determine HBsAg is an accurate assay for screening for HBsAg in HIV-1 infected patients at the point of care and may further help to guide cART in Sub-Saharan Africa. Public Library of Science 2013-03-01 /pmc/articles/PMC3585939/ /pubmed/23469281 http://dx.doi.org/10.1371/journal.pone.0058468 Text en © 2013 Franzeck et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Franzeck, Fabian C.
Ngwale, Ramadhani
Msongole, Bernadeta
Hamisi, Marian
Abdul, Omary
Henning, Lars
Letang, Emilio
Mwaigomole, Geoffrey
Battegay, Manuel
Hatz, Christoph
Tanner, Marcel
Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania
title Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania
title_full Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania
title_fullStr Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania
title_full_unstemmed Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania
title_short Viral Hepatitis and Rapid Diagnostic Test Based Screening for HBsAg in HIV-infected Patients in Rural Tanzania
title_sort viral hepatitis and rapid diagnostic test based screening for hbsag in hiv-infected patients in rural tanzania
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585939/
https://www.ncbi.nlm.nih.gov/pubmed/23469281
http://dx.doi.org/10.1371/journal.pone.0058468
work_keys_str_mv AT franzeckfabianc viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT ngwaleramadhani viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT msongolebernadeta viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT hamisimarian viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT abdulomary viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT henninglars viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT letangemilio viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT mwaigomolegeoffrey viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT battegaymanuel viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT hatzchristoph viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania
AT tannermarcel viralhepatitisandrapiddiagnostictestbasedscreeningforhbsaginhivinfectedpatientsinruraltanzania